BridgeMD
New treatment option for Systemic Lupus Erythematosus Related Interstial Lung Disease
Official title Interleukin23 in Systemic Lupus
ClinicalTrials.gov ID: NCT06713187
What this study is testing
What is interleukin 23?
interleukin 23 is an investigational medicine, being studied as a potential treatment for systemic lupus erythematosus related interstial lung disease.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- assement of interleukin 23 in serum of patients with systemic lupus erythematosus related interstial lung disease .
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 60. Healthy volunteers may be eligible.
You may be able to join if
- patients with systemic lupus erythematous and patients with systemic lupus erythematosus with interstial lung disease.
You likely can't join if
- patients with chest conditions rather than interstial lung disease \&who receiving biological blocking antibodies\& those treated with...
The study team makes the final eligibility decision.
Where it's taking place
- Sohag, Egypt
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 60 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Sohag, Egypt. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.